Molecular design and delivery of siRNA

Double stranded short interfering RNAs (siRNAs) mediate gene silencing in a sequence specific manner. By virtue of their specific gene silencing activity and owing to the recent discoveries on their plasmid and virus driven expression, siRNAs are being widely adopted in research and therapeutics. Efforts were made to optimize the siRNA expression system for the application in therapy. One major obstacle in developing RNA interference (RNAi) therapy is the delivery of siRNAs to the target cells. Combination of novel molecular targeting technologies, such as recombinant protein technology and ribosome display technology, will enable to deliver gene silencing agents to target cells specifically and efficiently.

[1]  K. Taira,et al.  Short hairpin type of dsRNAs that are controlled by tRNA(Val) promoter significantly induce RNAi-mediated gene silencing in the cytoplasm of human cells. , 2003, Nucleic acids research.

[2]  A. Ellington,et al.  Crystal structures of a series of RNA aptamers complexed to the same protein target , 1998, Nature Structural Biology.

[3]  S. Kawakami,et al.  In Vivo Gene Delivery to the Liver Using Novel Galactosylated Cationic Liposomes , 2000, Pharmaceutical Research.

[4]  G. P. Smith,et al.  Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. , 1985, Science.

[5]  O. Uhlenbeck,et al.  A thermodynamic analysis of the sequence-specific binding of RNA by bacteriophage MS2 coat protein. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Additional RNA-protein interactions facilitate in vitro selection by ribosome display , 2005 .

[7]  J. M. Thomson,et al.  Argonaute2 Is the Catalytic Engine of Mammalian RNAi , 2004, Science.

[8]  A. Ellington,et al.  Crystal structure of an RNA aptamer–protein complex at 2.8 Å resolution , 1998, Nature Structural Biology.

[9]  Ernst Wagner,et al.  Novel shielded transferrin-polyethylene glycol-polyethylenimine/DNA complexes for systemic tumor-targeted gene transfer. , 2003, Bioconjugate chemistry.

[10]  P. Rowley,et al.  Inhibition of telomerase activity in human cancer cells by RNA interference. , 2003, Molecular cancer therapeutics.

[11]  J. Murray,et al.  The three-dimensional structures of two complexes between recombinant MS2 capsids and RNA operator fragments reveal sequence-specific protein-RNA interactions. , 1997, Journal of molecular biology.

[12]  T. Irimura,et al.  Antitumor Activity of Small Interfering RNA/Cationic Liposome Complex in Mouse Models of Cancer , 2004, Clinical Cancer Research.

[13]  S. Asano,et al.  Maxizymes and small hairpin-type RNAs that are driven by a tRNA promoter specifically cleave a chimeric gene associated with leukemia in vitro and in vivo. , 2003, Cancer research.

[14]  J. Lisziewicz,et al.  Gene Therapy Approaches to HIV Infection , 2002, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[15]  T. Du,et al.  Asymmetry in the Assembly of the RNAi Enzyme Complex , 2003, Cell.

[16]  A. Pasquinelli,et al.  A Cellular Function for the RNA-Interference Enzyme Dicer in the Maturation of the let-7 Small Temporal RNA , 2001, Science.

[17]  Matthias John,et al.  Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs , 2004, Nature.

[18]  Inder M Verma,et al.  A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[19]  B. Li,et al.  Expression profiling reveals off-target gene regulation by RNAi , 2003, Nature Biotechnology.

[20]  Ali Ehsani,et al.  Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells , 2002, Nature Biotechnology.

[21]  Simple and rapid synthesis of siRNA derived from in vitro transcribed shRNA. , 2003, Nucleic acids research. Supplement.

[22]  S. Hammond,et al.  An RNA-directed nuclease mediates post-transcriptional gene silencing in Drosophila cells , 2000, Nature.

[23]  G. Hannon,et al.  Crystal Structure of Argonaute and Its Implications for RISC Slicer Activity , 2004, Science.

[24]  G. Hannon,et al.  Germline transmission of RNAi in mice , 2003, Nature Structural Biology.

[25]  A. Fire,et al.  Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[26]  A. Pasquinelli,et al.  Genes and Mechanisms Related to RNA Interference Regulate Expression of the Small Temporal RNAs that Control C. elegans Developmental Timing , 2001, Cell.

[27]  S. Kawakami,et al.  Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. , 2004, Biochemical and biophysical research communications.

[28]  W. Marasco,et al.  Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells , 2001, Cancer Gene Therapy.

[29]  Patrick J. Paddison,et al.  Stable suppression of gene expression by RNAi in mammalian cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[30]  Judy Lieberman,et al.  Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors , 2005, Nature Biotechnology.

[31]  Ki-Young Lee,et al.  Cloned zebrafish by nuclear transfer from long-term-cultured cells , 2002, Nature Biotechnology.

[32]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[33]  S. Jayasena,et al.  Functional siRNAs and miRNAs Exhibit Strand Bias , 2003, Cell.

[34]  K. Taira,et al.  Strategies for generation of an siRNA expression library directed against the human genome. , 2003, Oligonucleotides.

[35]  K. Taira,et al.  Effects on RNA interference in gene expression (RNAi) in cultured mammalian cells of mismatches and the introduction of chemical modifications at the 3'-ends of siRNAs. , 2002, Antisense & nucleic acid drug development.

[36]  Leaf Huang,et al.  Antibody-directed liposomes as drug-delivery vehicles , 1989 .

[37]  D. Engelke,et al.  Effective expression of small interfering RNA in human cells , 2002, Nature Biotechnology.

[38]  A. Plückthun,et al.  In vitro selection and evolution of functional proteins by using ribosome display. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[39]  Judy Lieberman,et al.  RNA interference targeting Fas protects mice from fulminant hepatitis , 2003, Nature Medicine.

[40]  K. Taira,et al.  U6 promoter–driven siRNAs with four uridine 3′ overhangs efficiently suppress targeted gene expression in mammalian cells , 2002, Nature Biotechnology.

[41]  Tyra G. Wolfsberg,et al.  Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[42]  T. Rana,et al.  siRNA function in RNAi: a chemical modification analysis. , 2003, RNA.

[43]  A. Caudy,et al.  Role for a bidentate ribonuclease in the initiation step of RNA interference , 2001 .

[44]  Thomas Tuschl,et al.  RISC is a 5' phosphomonoester-producing RNA endonuclease. , 2004, Genes & development.

[45]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[46]  M. Banan,et al.  The ins and outs of RNAi in mammalian cells. , 2004, Current pharmaceutical biotechnology.

[47]  E. Nabel,et al.  Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Fire,et al.  Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans , 1998, Nature.

[49]  P. Wils,et al.  Folate-targeted, cationic liposome-mediated gene transfer into disseminated peritoneal tumors , 2002, Gene Therapy.